Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001178913-25-001277·SPHERA FUNDS MANAGEMENT LTD.
Schedule 13G ownership disclosure
SKYE BIOSCIENCE INC
Common Stock, Par Value $0.001 · CUSIP: 83086J200
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Sphera Funds Management Ltd.
Shares: 1,476,353 · Class: 4.77%
- Sphera Global Healthcare GP Ltd.
Shares: 1,476,353 · Class: 4.77%
- Sphera Global Healthcare Management LP.
Shares: 1,476,353 · Class: 4.77%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001178913-25-001277
- Form type
- SCHEDULE 13G/A
- Filer
- SPHERA FUNDS MANAGEMENT LTD.
- CIK
- CIK 1496201
- Filed
- Apr 10, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership